174 related articles for article (PubMed ID: 30099396)
1. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial.
Li Z; Shan F; Ying X; Zhang L; Ren H; Li S; Jia Y; Miao R; Xue K; Li Z; Wang Y; Yan C; Zhang Y; Pang F; Ji J
BMJ Open; 2018 Aug; 8(8):e021633. PubMed ID: 30099396
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Laparoscopic Distal Gastrectomy After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Randomized Clinical Trial.
Li Z; Shan F; Ying X; Zhang Y; E JY; Wang Y; Ren H; Su X; Ji J
JAMA Surg; 2019 Dec; 154(12):1093-1101. PubMed ID: 31553463
[TBL] [Abstract][Full Text] [Related]
3. Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial.
Zhang X; Liang H; Li Z; Xue Y; Wang Y; Zhou Z; Yu J; Bu Z; Chen L; Du Y; Wang X; Wu A; Li G; Su X; Xiao G; Cui M; Wu D; Chen L; Wu X; Zhou Y; Zhang L; Dang C; He Y; Zhang Z; Sun Y; Li Y; Chen H; Bai Y; Qi C; Yu P; Zhu G; Suo J; Jia B; Li L; Huang C; Li F; Ye Y; Xu H; Wang X; Yuan Y; E JY; Ying X; Yao C; Shen L; Ji J;
Lancet Oncol; 2021 Aug; 22(8):1081-1092. PubMed ID: 34252374
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized Phase II trial (LANDSCOPE trial).
Yoshikawa T; Fukunaga T; Taguri M; Kunisaki C; Sakuramoto S; Ito S; Morita S; Tsuburaya A
Jpn J Clin Oncol; 2012 Jul; 42(7):654-7. PubMed ID: 22547727
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
6. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
7. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer after neoadjuvant chemotherapy: safety and short-term oncologic results.
Li Z; Shan F; Wang Y; Li S; Jia Y; Zhang L; Yin D; Ji J
Surg Endosc; 2016 Oct; 30(10):4265-71. PubMed ID: 27287914
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial.
Katai H; Mizusawa J; Katayama H; Morita S; Yamada T; Bando E; Ito S; Takagi M; Takagane A; Teshima S; Koeda K; Nunobe S; Yoshikawa T; Terashima M; Sasako M
Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):142-151. PubMed ID: 31757656
[TBL] [Abstract][Full Text] [Related]
9. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
10. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ; Kim YW; Yang HK; Chung HC; Park YK; Lee KH; Lee KW; Kim YH; Noh SI; Cho JY; Mok YJ; Kim YH; Ji J; Yeh TS; Button P; Sirzén F; Noh SH;
Lancet; 2012 Jan; 379(9813):315-21. PubMed ID: 22226517
[TBL] [Abstract][Full Text] [Related]
12. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
Fujitani K; Yang HK; Mizusawa J; Kim YW; Terashima M; Han SU; Iwasaki Y; Hyung WJ; Takagane A; Park DJ; Yoshikawa T; Hahn S; Nakamura K; Park CH; Kurokawa Y; Bang YJ; Park BJ; Sasako M; Tsujinaka T;
Lancet Oncol; 2016 Mar; 17(3):309-318. PubMed ID: 26822397
[TBL] [Abstract][Full Text] [Related]
13. The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
Wang X; Li S; Sun Y; Li K; Shen X; Xue Y; Liang P; Li G; Chen L; Zhao Q; Li G; Fu W; Liang H; Xin H; Suo J; Fang X; Zheng Z; Xu Z; Chen H; Zhou Y; He Y; Huang H; Zhu L; Yang K; Ji J; Ye Y; Zhang Z; Li F; Wang X; Tian Y; Park S; Chen L
BMC Cancer; 2021 Jan; 21(1):20. PubMed ID: 33402102
[TBL] [Abstract][Full Text] [Related]
14. Well-designed retrospective study versus small-sample prospective study in research based on laparoscopic and open radical distal gastrectomy for advanced gastric cancer.
Wang JB; Zhong Q; Chen QY; Lin GT; Liu ZY; Huang XB; Xie JW; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Zheng CH; Huang CM; Li P
Surg Endosc; 2020 Oct; 34(10):4504-4515. PubMed ID: 31720795
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.
Noh SH; Park SR; Yang HK; Chung HC; Chung IJ; Kim SW; Kim HH; Choi JH; Kim HK; Yu W; Lee JI; Shin DB; Ji J; Chen JS; Lim Y; Ha S; Bang YJ;
Lancet Oncol; 2014 Nov; 15(12):1389-96. PubMed ID: 25439693
[TBL] [Abstract][Full Text] [Related]
16. Short-term Outcomes of a Multicenter Randomized Controlled Trial Comparing Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy to Open Distal Gastrectomy for Locally Advanced Gastric Cancer (KLASS-02-RCT).
Lee HJ; Hyung WJ; Yang HK; Han SU; Park YK; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Kim MC;
Ann Surg; 2019 Dec; 270(6):983-991. PubMed ID: 30829698
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.
Bouras G; Lee SW; Nomura E; Tokuhara T; Tsunemi S; Tanigawa N
Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):424-8. PubMed ID: 22146165
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study.
Endo S; Terazawa T; Goto M; Tanaka R; Kato T; Fujitani K; Kawakami H; Sakai D; Kurokawa Y; Tsujinaka T; Shimokawa T; Satoh T
BMC Cancer; 2022 Jul; 22(1):811. PubMed ID: 35870893
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer in middle-low-volume centers in Western countries: a propensity score matching analysis.
Garbarino GM; Costa G; Laracca GG; Castagnola G; Mercantini P; Di Paola M; Vita S; Masoni L
Langenbecks Arch Surg; 2020 Sep; 405(6):797-807. PubMed ID: 32754848
[TBL] [Abstract][Full Text] [Related]
20. Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
Surgery; 2019 Jun; 165(6):1211-1216. PubMed ID: 30772006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
